
|Articles|May 10, 2004
Sacral stimulation: Improvements in QoL fade over the long term
Although quality of life improves significantly 6 months after treatmentwith sacral neuromodulation for voiding dysfunction, the reported qualityof life indicators are not statistically significant in the long term. However,not even the mitigation of symptoms is enough to keep patients happy overtime, said Anurag K. Das, MD, during a presentation at the AUA meeting Sunday.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Optimizing care for men with overactive bladder, with Keith Xavier, MD
4
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH
5






